Abstract
Bariatric surgery results in sustained weight loss, improvement of metabolic and hormonal changes, and reduction of comorbidities in obese patients. However, beneficial effects of bariatric surgery are not solely explained by restriction and malabsorption induced by surgery itself. Changes in the microbiome might play a role in this mechanism. A systematic review was performed in which 21 studies were included. The microbiome was affected by surgery and profound changes occurred in the first year of follow-up. An increase in Bacteroides and Proteobacteria and a decrease in Firmicutes were observed postoperatively in most studies. These changes were associated with weight loss. Bariatric surgery induces profound changes in the microbiome. This may be related to the beneficial effect of bariatric surgery on comorbidities associated with obesity.
Similar content being viewed by others
References
Flegal KM. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav. 2005;86:599–602.
Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes. 2013;37:889–91.
Kushner RF, Kahan S. Introduction: the state of obesity in 2017. Med Clin North Am. 2018;102:1–11.
Lazzati A, Guy-Lachuer R, Delaunay V, et al. Bariatric surgery trends in France: 2005-2011. Surg Obes Relat Dis. 2014;10:328–34.
Tadross JA, le Roux CW. The mechanisms of weight loss after bariatric surgery. Int J Obes. 2009;33(Suppl 1):S28–32.
Federico A, Dallio M, Tolone S, et al. Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: effect of bariatric surgery. In vivo. 2016;30:321–30.
Reames BN, Finks JF, Bacal D, et al. Changes in bariatric surgery procedure use in Michigan, 2006-2013. JAMA. 2014;312:959–61.
Memarian E, Calling S, Sundquist K, et al. Sociodemographic differences and time trends of bariatric surgery in Sweden 1990-2010. Obes Surg. 2014;24:2109–16.
Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 2007;10:729–34.
Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31.
Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178ra41.
Haskins IN, Corcelles R, Froylich D, et al. Primary inadequate weight loss after Roux-en-Y gastric bypass is not associated with poor cardiovascular or metabolic outcomes: experience from a single institution. Obes Surg. 2017;27:676–80.
Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049–57.
Akbay E, Yetkin I, Ersoy R, et al. The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus. Diabetes Nutr Metab. 2004;17:331–5.
Kang Y, Cai Y. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy. Hormones. 2017;16:223–34.
Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;20:411–7.
Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070–5.
Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541–6.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106:2365–70.
Graessler J, Qin Y, Zhong H, et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J. 2013;13:514–22.
Kong LC, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013;98:16–24.
Damms-Machado A, Mitra S, Schollenberger AE, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015;2015:806248.
Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22:228–38.
Patrone V, Vajana E, Minuti A, et al. Postoperative changes in fecal bacterial communities and fermentation products in obese patients undergoing bilio-intestinal bypass. Front Microbiol. 2016;7:200.
Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8:67.
Murphy R, Evennett NJ, Clarke MG, et al. Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol. BMJ Open. 2016;6:e011416.
Ilhan ZE, DiBaise JK, Isern NG, et al. Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding. ISME J. 2017;11:2047–58.
Sanmiguel CP, Jacobs J, Gupta A, et al. Surgically induced changes in gut microbiome and hedonic eating as related to weight loss: preliminary findings in obese women undergoing bariatric surgery. Psychosom Med. 2017;79:880–7.
Medina DA, Pedreros JP, Turiel D, et al. Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients. PeerJ. 2017;5:e3443.
Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23:859–68.
Chen H, Qian L, Lv Q, et al. Change in gut microbiota is correlated with alterations in the surface molecule expression of monocytes after Roux-en-Y gastric bypass surgery in obese type 2 diabetic patients. Am J Transl Res. 2017;9:1243–54.
Campisciano G, Cason C, Palmisano S, et al. Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. Front Biosci (Elite Ed). 2018;10:495–505.
Campisciano G, Palmisano S, Cason C, et al. Gut microbiota characterisation in obese patients before and after bariatric surgery. Benefic Microbes. 2018;9:367–73.
Aron-Wisnewsky J, Prifti E, Belda E, Ichou F, Kayser BD, Dao MC, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68(1):70–82
Kikuchi R, Irie J, Yamada-Goto N, et al. The impact of laparoscopic sleeve gastrectomy with duodenojejunal bypass on intestinal microbiota differs from that of laparoscopic sleeve gastrectomy in Japanese patients with obesity. Clin Drug Investig. 2018;38:545–52.
Kumar R, Grams J, Chu DI, et al. New microbe genomic variants in patients fecal community following surgical disruption of the upper human gastrointestinal tract. HUMIC. 2018;10:37–42.
Cortez RV, Petry T, Caravatto P, et al. Shifts in intestinal microbiota after duodenal exclusion favor glycemic control and weight loss: a randomized controlled trial. Surg Obes Relat Dis. 2018;14:1748–54.
Hong S-H, Bunge J, Jeon S-O, et al. Predicting microbial species richness. Proc Natl Acad Sci U S A. 2006;103:117–22.
Li M, Wang B, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A. 2008;105:2117–22.
Murphy R, Tsai P, Jullig M, et al. Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg. 2017;27:917–25.
Backhed F, Manchester JK, Semenkovich CF, et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104:979–84.
Gagliardi A, Totino V, Cacciotti F, et al. Rebuilding the gut microbiota ecosystem. Int J Environ Res Public Health. 2018;15(8)
Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1–10.
Costello SP, Waters O, Bryant RV, et al. Short duration, low intensity, pooled fecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. Gastroenterology. 2017;152:S198–S9.
Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389:1218–28.
Khanna S, Vazquez-Baeza Y, Gonzalez A, et al. Changes in microbial ecology after fecal microbiota transplantation for recurrent C difficile infection affected by underlying inflammatory bowel disease. Microbiome. 2017;5:55.
van Praagh JB, de Goffau MC, Bakker IS, et al. Intestinal microbiota and anastomotic leakage of stapled colorectal anastomoses: a pilot study. Surg Endosc. 2016;30:2259–65.
van Praagh JB, de Goffau MC, Bakker IS, van Goor H, Harmsen HJM, Olinga P, et al. Mucus microbiome of anastomotic tissue during surgery has predictive value for colorectal anastomotic leakage. Ann Surg. 2018. [ePub ahead of print]
Reddy RM, Weir WB, Barnett S, et al. Increased variance in oral and gastric microbiome correlates with esophagectomy anastomotic leak. Ann Thorac Surg. 2018;105:865–70.
Castaner O, Goday A, Park YM, et al. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol. 2018;2018:4095789.
Liu H, Hu C, Zhang X, et al. Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Investig. 2018;9:13–20.
Guo Y, Huang ZP, Liu CQ, et al. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Eur J Endocrinol. 2018;178:43–56.
Ejtahed HS, Angoorani P, Hasani-Ranjbar S, et al. Adaptation of human gut microbiota to bariatric surgeries in morbidly obese patients: a systematic review. Microb Pathog. 2018;116:13–21.
Author information
Authors and Affiliations
Contributions
All authors equally contributed to this paper. Conception and design of the study: ML and GN; literature review and analysis: JL and GV; drafting and critical revision and editing, and final approval of the final version: JL, GV, ML, and GN.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Statements Regarding Ethics and Consent
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Core Tip
Bariatric surgery is associated with rapid and sustained alterations in the gut microbiome, with more pronounced changes in patients undergoing Roux-en-Y gastric bypass compared with sleeve gastrectomy. Furthermore, an increase of diversity and microbial richness of the human microbiome was observed following bariatric surgery. This may be related to the beneficial effect of bariatric surgery on comorbidities associated with obesity, such as type 2 diabetes. Unraveling the exact correlations between alterations in microbiome and bariatric surgery is challenging and may provide new therapeutic opportunities to reduce morbid obesity.
Appendices
Appendix 1. Full search strategy
PubMed
(“gastrointestinal microbiome” OR microbiome OR microbioom OR microbioma) AND (“gastric band” OR “obesity surgery” OR RYGB OR “Roux-en-Y gastric bypass” OR “biliopancreatic diversion” OR DJB OR “duodenal-jejunal bypass” OR gastrojejunostomies OR gastrojejunostomy OR “sleeve gastrectomy” OR “bariatric surgery” OR “upper gastrointestinal surgery” OR “gastric surgery”)
Embase
(“gastric band” or “bariatric surgery” or “upper gastrointestinal surgery” or “gastric surgery” or “sleeve gastrectomy” or gastrojejunostomy or gastrojejunostomies or “duodenal-jejunal bypass” or “biliopancreatic diversion” or “Roux-en-Y gastric bypass” or DJB or RYGB or “obesity surgery”).af. AND (“gastrointestinal microbiome” or microbiome or microbioom or microbioma).af.
Appendix 2 Quality Assessment
Rights and permissions
About this article
Cite this article
Luijten, J.C.H.B.M., Vugts, G., Nieuwenhuijzen, G.A.P. et al. The Importance of the Microbiome in Bariatric Surgery: a Systematic Review. OBES SURG 29, 2338–2349 (2019). https://doi.org/10.1007/s11695-019-03863-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-019-03863-y